← Leaderboards
Brian Richard McNaughton
Delaware State University
$3,037,469
Attributed
$3,037,469
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,037,469 · 5
By mechanism
U54$2,599,469 · 4
R15$438,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Delaware State University
Same institution · by research overlap
- Hakeem O Lawal$1,766,551
- M Shahidul Islam$366,308
Others in their field
Other Rising Stars on “Member”
- Brian Zavertnik · Palantir Technologies, Inc.$33,059,912
- Joan Grand · Mitre Corporation$32,826,287
- Eric M Benway · Woods Hole Oceanographic Institution$32,293,242
- Bridget Murphy · Broad Institute, Inc.$23,600,775
- Alanna Maguire · Mayo Clinic Rochester$16,353,346
- Joost Van Der Zwaag · University Of California-San Diego Scripps Inst Of Oceanography$14,814,950
Research focus
MemberDelawareMinority GroupsRecruitHealth EquityStructureLinkFundingScientistSuccessProgramsResearch PersonnelCommunity Engaged ResearchApplications GrantsCommunity EngagementCommunity Based ResearchCommunitiesCommunity CenterComplexBindingCellsCessation Of LifeBehaviorAdoption
Grant awards (9)
Investigator Development$43,301
U54 · FY2025 · MD · contact PI
Investigator Development$637,442
U54 · FY2024 · MD · contact PI
Integrating Low-Cost Paper-Based Devices and Personalized Immunotherapeutics to Treat Triple Negative Breast Cancer$368,987
U54 · FY2024 · MD · contact PI
Investigator Development$43,301
U54 · FY2024 · MD · contact PI
Investigator Development$628,377
U54 · FY2023 · MD · contact PI
Integrating Low-Cost Paper-Based Devices and Personalized Immunotherapeutics to Treat Triple Negative Breast Cancer$370,300
U54 · FY2023 · MD · contact PI
Evolved RNA Recognition Motifs for Therapeutic and Gene EditingApplications$438,000
R15 · FY2022 · GM · contact PI
Integrating Low-Cost Paper-Based Devices and Personalized Immunotherapeutics to Treat Triple Negative Breast Cancer$328,239
U54 · FY2022 · MD · contact PI
Investigator Development$179,522
U54 · FY2022 · MD · contact PI